Erick Berglund, PhD, Chief Executive Officer: Dr. Berglund received his BS and MS from the University of N.H. and Boston University School of Medicine, respectively, then received his PhD in biochemistry from Goethe University in Frankfurt, Germany. He initially worked as a researcher at Sanofi‐Aventis, then became a USPTO registered patent agent, going on to work in business development and strategy at Kyorin Pharmaceuticals, and then as CEO of Vaxiva KK, a Tokyo-based vaccine company. Prior to launching Allovate, Dr. Berglund was a Medical Strategy Director at H4B Chelsea, a global healthcare communications consultancy in NYC.
Michael Nelson, JD, Chief Financial Officer: Mr. Nelson graduated from Cornell University and received his J.D. from New York University School of Law. Previously, he was chief financial officer & general counsel of an early stage healthcare company, was an analyst at Barclays Capital and ING, was an investment banker at Westwood Capital and CIBC World Markets and practiced law at Willkie Farr & Gallagher and Dewey Ballantine. Mr. Nelson is currently the CEO of Intrommune Therapeutics and CFO of Immunovent, LLC and a senior healthcare advisor at Westwood Capital, LLC.
Anthony Robinson, MS, CRNP, MBA, Clinical Advisor: Mr. Robinson received his BS Anthony Robinson, MS, CRNP, MBAfrom Cornell University, his MS from MCP Hahnemann University and his MBA from The Pennsylvania State University. He worked in psychiatry and internal medicine services as a clinician, and then was responsible for clinical drug development of early through late state pharmaceutical products at Covance and Shire. Mr. Robinson currently is the Chief Operating Officer for Intrommune Therapeutics and an advisor to Immunovent, LLC.
William Reisacher, MD, Senior Scientific Advisor: Dr. Reisacher graduated from Cornell University and received his medical degree from the Mount Sinai School of Medicine with distinction in research. His clinical expertise lies in the diagnosis and management of airborne and food allergies in adults and children. He completed his allergy fellowship through the American Academy of Otolaryngic Allergy (AAOA) in 2005. Dr. Reisacher is a General Otolaryngologist and Otolaryngic Allergist on the full-time Faculty of Weill Cornell Medical College, where he is Associate Professor of Otolaryngology and the Director of Allergy within the Department of Otolaryngology-Head and Neck Surgery. He has served on the Board of Directors of the AAOA, currently serves on the Board of Governors of the American Academy of Otolaryngology – Head and Neck Surgery and has lectured both nationally and internationally.
Danya Glabau, PhD, Medical Affairs Advisor: Ms. Glabau graduated from Cornell University with a Bachelor’s degree in biology and received her PhD in Science and Technology Studies (specializing in Medical Anthropology) from Cornell University. Her academic research examined food allergy patient experience, needs, and treatment decision making. Prior to joining Allovate, she conducted social science research and taught social science courses at Cornell University, and she previously worked in freelance healthcare public relations in New York, student services at Cornell University, and science communications and research coordination at a science museum and at Cornell University. Dr. Glabau is currently Director of Medical Affairs at Intrommune Therapeutics and Associate Faculty at the Brooklyn Institute for Social Research.
Kate Rochlin, PhD, Scientific Consultant: Dr. Rochlin is an accomplished scientist with over 10 years of molecular biology and biochemistry research experience. Dr. Rochlin earned her PhD in Biochemistry and Cellular Biology at Weill-Cornell College of Medicine and has consulting experience with several healthcare and financial companies including Pfizer, Russo Partners and JMP Securities. Dr. Rochlin is also a founder and Chief Scientific Officer of Immunovent, an allergy diagnostic company.
Jay Gruhlkey, MD, Scientific Advisor: Dr. Gruhlkey has been a primary care physician in Austin, Texas for over 10 years. Dr. Gruhlkey is the President of the Pan American Allergy Society and a faculty member of the National Procedure Institute (NPI) where he has trained over 1,500 primary care, internists, pediatric physicians, and ENT Specialists in the disciplines of Allergy Testing & Treatment. Dr. Gruhlkey is a well-known and respected figure in the Allergy and Immunology industry and has been the recipient of numerous leadership awards throughout his career. Dr. Gruhlkey graduated with a BS in Chemistry from Texas A&M University and an MD from The University of Texas Health Science Center – Houston. He completed his residency in Family Medicine at Southwest Memorial Hospital in Houston, where he served as Chief Resident. Dr. Gruhlkey received the Mead Johnson Award for Graduate Medical Education in 2000 and AMA Foundation Leadership Award in 2003.